Protagonist Therapeutics Inc buy BTIG Research
Start price
24.07.24
/
50%
€50.50
Target price
24.07.25
€46.93
Performance (%)
-4.16%
End price
25.07.25
€48.40
Summary
This prediction ended on 25.07.25 with a price of €48.40. With a performance of -4.16%, the BUY prediction by BTIG_Research finished with a loss. BTIG_Research has a follow-up prediction for Protagonist Therapeutics Inc where he still thinks Protagonist Therapeutics Inc is a Buy. BTIG_Research has 50% into this predictionPerformance without dividends (%)
| Name | 1w | 1m | 1y |
|---|---|---|---|
| Protagonist Therapeutics Inc | 6.040% | 6.040% | 262.385% |
| iShares Core DAX® | -3,99 % | -2,81 % | 4,16 % |
| iShares Nasdaq 100 | 0,35 % | -0,75 % | 9,47 % |
| iShares Nikkei 225® | -3,85 % | 4,23 % | 28,36 % |
| iShares S&P 500 | 0,30 % | 0,38 % | 6,14 % |
Comments by BTIG_Research for this prediction
In the thread Protagonist Therapeutics Inc diskutieren
Protagonist Therapeutics, Inc. (NASDAQ: PTGX) had its price target raised by analysts at BTIG Research from $41.00 to $51.00. They now have a "buy" rating on the stock.
Ratings data for PTGX provided by MarketBeat
In the thread Trading Protagonist Therapeutics Inc
Die von BTIG_Research gewählte maximale Laufzeit wurde überschritten
Current prediction by BTIG_Research for Protagonist Therapeutics Inc
Protagonist Therapeutics Inc
Start price
Target price
Perf. (%)
€66.00
28.10.25
28.10.25
€70.34
28.10.26
28.10.26
19.70%
03.03.26
03.03.26
